Pfizer’s Albert Bourla to receive the AACR Outstanding Achievement Award for Service to Cancer Science and Medicine

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Albert Bourla, Pfizer’s chairman and CEO, will receive the 2024 the American Association for Cancer Research Outstanding Achievement Award for Service to Cancer Science and Medicine during the AACR Annual Meeting 2024, to be held April 5-10 in San Diego, California. 

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

Login